These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1200025)
1. Oral polio vaccination of children in the tropics. II. Antibody response in relation to vaccine virus infection. John TJ Am J Epidemiol; 1975 Nov; 102(5):414-21. PubMed ID: 1200025 [TBL] [Abstract][Full Text] [Related]
2. Oral polio vaccination of children in the tropics. III. Intercurrent enterovirus infections, vaccine virus take and antibody response. John TJ; Christopher S Am J Epidemiol; 1975 Nov; 102(5):422-8. PubMed ID: 1200026 [TBL] [Abstract][Full Text] [Related]
3. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. John TJ; Jayabal P Am J Epidemiol; 1972 Oct; 96(4):263-9. PubMed ID: 4342327 [No Abstract] [Full Text] [Related]
4. Quantity of Vaccine Poliovirus Shed Determines the Titer of the Serum Neutralizing Antibody Response in Indian Children Who Received Oral Vaccine. Giri S; Kumar N; Dhanapal P; Venkatesan J; Kasirajan A; Iturriza-Gomara M; John J; Abraham AM; Grassly NC; Kang G J Infect Dis; 2018 Apr; 217(9):1395-1398. PubMed ID: 29300947 [TBL] [Abstract][Full Text] [Related]
5. Anomalous observations on IPV and OPV vaccination. John TJ Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial. Estívariz CF; Jafari H; Sutter RW; John TJ; Jain V; Agarwal A; Verma H; Pallansch MA; Singh AP; Guirguis S; Awale J; Burton A; Bahl S; Chatterjee A; Aylward RB Lancet Infect Dis; 2012 Feb; 12(2):128-35. PubMed ID: 22071249 [TBL] [Abstract][Full Text] [Related]
7. Immunization against poliomyelitis: risk/benefit/cost in a changing context. Salk J Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106 [TBL] [Abstract][Full Text] [Related]
8. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial. Asturias EJ; Bandyopadhyay AS; Self S; Rivera L; Saez-Llorens X; Lopez E; Melgar M; Gaensbauer JT; Weldon WC; Oberste MS; Borate BR; Gast C; Clemens R; Orenstein W; O'Ryan G M; Jimeno J; Clemens SA; Ward J; Rüttimann R; Lancet; 2016 Jul; 388(10040):158-69. PubMed ID: 27212429 [TBL] [Abstract][Full Text] [Related]
9. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study. O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA; Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714 [TBL] [Abstract][Full Text] [Related]
10. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China. Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055 [TBL] [Abstract][Full Text] [Related]
11. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use. Duintjer Tebbens RJ; Hampton LM; Thompson KM BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198 [TBL] [Abstract][Full Text] [Related]
12. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related]
14. Oral poliovirus vaccine in tropical Africa: greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates. Heymann DL; Murphy K; Brigaud M; Aymard M; Tembon A; Maben GK Bull World Health Organ; 1987; 65(4):495-501. PubMed ID: 3500802 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes. Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770 [TBL] [Abstract][Full Text] [Related]
16. Vaccine control of poliomyelitis in the 1980s. Sabin AB Yale J Biol Med; 1982; 55(3-4):383-9. PubMed ID: 7180028 [TBL] [Abstract][Full Text] [Related]
17. [Results of immunization of seronegative children with live poliomyelitis vaccine]. Babaev AA Vopr Virusol; 1978; (5):553-6. PubMed ID: 153652 [TBL] [Abstract][Full Text] [Related]
18. Systemic and mucosal immune response to polio vaccination with additional dose in newborn period. Bhaskaram P; Nair KM; Hemalatha P; Murthy N; Nair P J Trop Pediatr; 1997 Aug; 43(4):232-4. PubMed ID: 9283127 [TBL] [Abstract][Full Text] [Related]
19. 2001 serological survey in the Czech Republic--poliomyelitis. Matyásová I; Rainetová P; Cástková J Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257 [TBL] [Abstract][Full Text] [Related]
20. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]